Four abstracts highlighting clinical data and real-world experience with MIPLYFFA accepted for presentation, including an oral presentation by ...

Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”) a clinical-stage biotechnology company focused on unlocking new therapeutic pathways for obesity and other metabolic health disorders, will present a ...

DANVILLE – Purdue Extension is inviting individuals and groups to apply to present research, outreach, or educational ...

SAN CARLOS, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea”) (Nasdaq: BMEA), a clinical-stage diabetes and obesity medicines company, today announced that it will present ...

TORONTO, September 29, 2025--(BUSINESS WIRE)--Satellos Bioscience Inc. (TSX: MSCL, OTCQB: MSCLF) ("Satellos" or the "Company"), a clinical-stage biotechnology company developing life-improving ...

Tralokinumab-ldrm is approved for the treatment of moderate-to-severe AD in adult and adolescent patients 12 years and older in the European Union, Canada, Great Britain, the United Arab Emirates, ...

Did you know the ESA annual meeting receives twice as many contributed abstracts for talks compared to posters? Over the past decade, only 1 out of every 3 contributed abstracts has been submitted for ...

Jul. 2—LORETTO, Pa. — This exhibition will have viewers strolling through the artistic process in posters. "The Art of the Poster: Mark Del Costello Poster Collection" exhibition is on display through ...